TY - JOUR
AU - Lavania M
AU - Darlong J
AU - Reddy A
AU - Ahuja M
AU - Singh I
AU - Turankar R
AU - Sengupta U
AB - A 25-year-old male treated for leprosy at the age of 15, with MDT, visited TLM Purulia Hospital in July 2017. He was provisionally diagnosed as a lepromatous relapse with ENL reaction. A biopsy was done to test for drug resistance. Drug resistance testing showed resistance to rifampicin. Second line drug regimen recommended by WHO for rifampicin-resistance was started. Within 6 months of taking medication the clinical signs and symptoms improved rapidly and the BI dropped by 1·66 log within 6 months. This case highlights the need for investigations in cases of relapse and the efficacy of WHO recommended second line drug regimen treatment in rifampicin-resistant leprosy cases.
BT - Leprosy review
IS - 4
LA - eng
N2 - A 25-year-old male treated for leprosy at the age of 15, with MDT, visited TLM Purulia Hospital in July 2017. He was provisionally diagnosed as a lepromatous relapse with ENL reaction. A biopsy was done to test for drug resistance. Drug resistance testing showed resistance to rifampicin. Second line drug regimen recommended by WHO for rifampicin-resistance was started. Within 6 months of taking medication the clinical signs and symptoms improved rapidly and the BI dropped by 1·66 log within 6 months. This case highlights the need for investigations in cases of relapse and the efficacy of WHO recommended second line drug regimen treatment in rifampicin-resistant leprosy cases.
PY - 2019
EP - 456–459
T2 - Leprosy review
TI - Successful treatment of rifampicin resistant case of leprosy by WHO recommended ofloxacin and minocycline regimen
UR - https://leprosyreview.org/article/90/4/19-0059
VL - 90
ER -